Lysulin, Inc.

Dexcom, Inc.

Oculir, Inc.

Other

Lifescan Corporation

Quidel Corporation

John Burd

William J Sell

Apurv Ullas Kamath

Peter C Simpson

James H Brauker

Paul V Goode, Jr

Robert James Boock

James R Petisce

Mark Allan Tapsak

Kum Ming Woo

Monica A Rixman

Melissa A Nicholas

Gary Krantz

Jacob Fraden

Gebhard Neyer

Rathburn K Rhodes

Talei Hoblitzell

Charles E Kramer

Robert S Galen

Mark C Shults

Rathbun K Rhodes

Allan D Pronovost

Peter Jacobs

Gerald L Rowley

Steven P Miller

Bart Chapman

Steven V Edelman

Systems and method that relate to improving levels, functions, and resistances related to chronic conditions by using lysine-based supplements are described. For example, a method of monitoring an analyte level may include administering a supplement that may include lysine, zinc, and vitamin C to a user. The method may also include monitoring an analyte level in a bio-sample before and after the supplement is administered.

Levels, functions, and resistances related to chronic conditions by using lysine-based supplements

A method of improving beta cell function by using a supplement, the comprising: administering the supplement comprising lysine, zinc, and vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample.

Method of improving beta cell function using a supplement

A method of preventing protein glycation using a supplement may comprise: administering a supplement comprising lysine and zinc; monitoring a concentration of glucose before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the concentration of glucose found in the bio-sample.

Prevention of protein glycation using lysine supplements

A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.

Inhibiting chronic blood and nephrological disorders using lysine-based supplements

Prevention of protein glycation using lysine/zinc supplements

A method of improving insulin resistance by using a supplement may include: administering the supplement including lysine, zinc, and vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample.

Insulin resistance and beta cell function using lysine-based supplements

A method of determining a stage of CKD may comprise: measuring a creatinine level; determining a creatinine level; determining a glomerular filtration rate; and determining a stage of CKD.

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.

Dual electrode system for a continuous analyte sensor

The present invention is related to non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject by measuring electromagnetic radiation signatures from the subject's conjunctiva. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods the conjunctiva of the subject with electromagnetic radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.

Methods for non-invasive analyte measurement from the conjunctiva

The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods a body surface of the subject, such as the subject's eye, with radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.

Methods and device for non-invasive analyte measurement

The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative of the subject's immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. Optionally, other analytes indicative of glycemic condition, such as ketone bodies or fatty acid derivatives, can also be measured. The present invention also provides a method of diagnosing diabetes. The invention additionally provides a method for analyzing the concentration of fructosamine in less than or equal to five minutes without the use of a reaction accelerator.

Combined assay for current glucose level and intermediate or long-term glycemic control

The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument measures the level of mid-infrared radiation from the subject's body surface, such as the eye, and determines a specific analyte's concentration based on said analyte's distinctive mid-infrared radiation signature.

Method and instruments for non-invasive analyte measurement

Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control

Growing community of inventors

San Diego, CA, United States of America

John Burd